Janssen-Cilag AG - Invega 3 mg, Retardtabletten | | 57961 | | 01 | | Invega 3 mg | | Retardtabletten | | N05AX13 | | Paliperidone | | 15.05.2008 | | |
| Composition | paliperidonum 3 mg, polyethyleni oxidum, natrii chloridum corresp. natrium 11.8 mg, povidonum K 29-32, acidum stearicum, E 172 (rubrum), E 321, Überzug: hydroxyethylcellulosum, macrogolum 3350, cellulosi acetas, hypromellosum, lactosum monohydricum 13.2 mg, triacetinum, cera carnauba, E 171, Drucktinte: hypromellosum, propylenglycolum, E 172 (nigrum), pro compresso obducto. | Packungsbestandteile | | Delayed release tablets | | | Active Agent | Dose |
---|
Paliperidonum | 3 mg |
| BAG: Active Agent | Dose |
---|
Paliperidonum | 3 mg |
| | Inactive agents | Dose | additional_information |
---|
(Nigrum) | | | (Rubrum) | | | Acidum Stearicum | | | Cellulosi Acetas | | | Cera Carnauba | | | E 171 | | color. | E 172 | | color. | E 321 | | color. | Hydroxyethylcellulosum | | Überzug | Hypromellosum | | Drucktinte | Lactose Monohydrate | 13.2 mg | | Macrogol | 3350 | | Sodium Chloride | | | Polyethyleni Oxidum | | | Povidonum K | 29-32 | | Pro Compresso Obducto | | | Propylenglycol | | | Triacetinum | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
001 | 28 Tablet(s) | 112.31 | 137.50 | B | SL | Yes |
|
|